LatchBio Stock

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

Sign up today and learn more about LatchBio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About LatchBio Stock

LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.

Funding History

January 2020$200K
October 2021$5.0M
June 2022$28.0M

Management

Co-Founder and CEO

Alfredo Andere

Co-founder and CTO

Kenny Workman

Co-founder, Chief Operating Officer

Kyle Giffin

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo